Systemic impact molds mesenchymal stromal/stem cell aging. 2015

Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
Institute for Biomedical Aging Research, University Innsbruck, Rennweg 10, Innsbruck A-6020, Austria.

Aging is associated with an accruing emergence of non-functional tissues. Mesenchymal stem cells (MSC) bring forth progenitors with multi-lineage differentiation potential, yet, they also exhibit anti-inflammatory and tissue-protective properties. Due to aging, altered tissue microenvironments constrict controlled stem cell proliferation and progenitor differentiation, thus diminishing the fitness of MSC. Therefore, deepening our understanding of metabolic, molecular and environmental factors impacting on MSC during human aging as well as providing new vistas on their role in promoting healthy aging and preventing age-associated disease is pivot. It is anticipated that integrative quantification of systemic parameters dominantly impacting on MSC will also enable effective personalized prognosis and provision of effective early medical interventions. Working along this line, it can be envisaged that standards in medical therapies can be individually adjusted by accounting not solely for the patient's chronological age or other physical parameters rather than specific physiological parameters which are believed to functionally shape stem cell niches within the bone marrow.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell

Related Publications

Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
December 2005, Experimental gerontology,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
March 2013, Regenerative medicine,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
January 2021, Stem cells (Dayton, Ohio),
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
August 2011, Current opinion in immunology,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
February 2020, Biomolecules,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
August 2016, Stem cell research & therapy,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
February 2022, The Lancet. Rheumatology,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
September 2021, eLife,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
February 2019, Stem cell research & therapy,
Stephan Reitinger, and Magdalena Schimke, and Sebastian Klepsch, and Snezana de Sneeuw, and Stella Lukas Yani, and Robert Gaßner, and Peter Ertl, and Günter Lepperdinger
June 2018, Lupus,
Copied contents to your clipboard!